Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Monitoring Agency Report_September 30, 2023
November 6, 2023
Outcome of Board Meeting_November 04, 2023
November 4, 2023
Intimation of Board Meeting_November 04, 2023
October 28, 2023
Intimation of Postal Ballot Process_October 2023
October 23, 2023
Disclosure under Regulation 30_October 2023
October 20, 2023
Certificate under Regulation 74(5)_September 30, 2023
October 12, 2023
Notice of Closure of Trading Window_September 30, 2023
September 29, 2023
Disclosure under Regulation 30_September 27, 2023
September 27, 2023
Intimation under Regulation 30_September 25, 2023
September 25, 2023
Press Release_Regulation 30_September 12, 2023
September 12, 2023
Monitoring Agency Report_June 30, 2023
August 14, 2023
Investor Call Recording_August 14, 2023
August 14, 2023
Newspaper Publication_Financial Results_June 30, 2023
August 12, 2023
Outcome of Board Meeting_August 10, 2023
August 10, 2023
Reconciliation of Share Capital Audit Report_June 30, 2023
July 21, 2023
Newspaper Advertisement_July 19, 2023
July 19, 2023
Previous
1
...
Next
11 / 36